GWP42003-P
( DrugBank: - / KEGG DRUG: - )
6 diseases
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 140 | Dorabe syndrome | 16 |
| 143 | Epilepsy with myoclonic-atonic seizures | 1 |
| 144 | Lennox-Gastaut syndrome | 14 |
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 145 | West syndrome | 3 |
| 156 | Rett syndrome | 7 |
| 158 | Tuberous sclerosis | 6 |
140. Dorabe syndrome
Clinical trials : 139 / Drugs : 49 - (DrugBank : 17) / Drug target genes : 53 - Drug target pathways : 67
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
143. Epilepsy with myoclonic-atonic seizures
Clinical trial : 1 / Drug : 1 - (DrugBank : 0) / Drug target gene : 0 - Drug target pathway : 0
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
144. Lennox-Gastaut syndrome
Clinical trials : 128 / Drugs : 53 - (DrugBank : 13) / Drug target genes : 50 - Drug target pathways : 62
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
145. West syndrome
Clinical trials : 49 / Drugs : 43 - (DrugBank : 16) / Drug target genes : 29 - Drug target pathways : 28
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
156. Rett syndrome
Clinical trials : 55 / Drugs : 51 - (DrugBank : 22) / Drug target genes : 77 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|
158. Tuberous sclerosis
Clinical trials : 129 / Drugs : 56 - (DrugBank : 20) / Drug target genes : 35 - Drug target pathways : 116
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|